1. Home
  2. HRMY vs VVX Comparison

HRMY vs VVX Comparison

Compare HRMY & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$39.00

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo V2X Inc.

VVX

V2X Inc.

HOLD

Current Price

$55.19

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
VVX
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
HRMY
VVX
Price
$39.00
$55.19
Analyst Decision
Strong Buy
Buy
Analyst Count
9
10
Target Price
$51.33
$62.60
AVG Volume (30 Days)
789.9K
294.5K
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
50.44
791.53
EPS
3.17
2.51
Revenue
$825,944,000.00
$4,419,142,000.00
Revenue This Year
$23.11
$4.42
Revenue Next Year
$16.15
$5.45
P/E Ratio
$12.79
$21.81
Revenue Growth
21.13
5.10
52 Week Low
$25.52
$41.08
52 Week High
$40.93
$63.74

Technical Indicators

Market Signals
Indicator
HRMY
VVX
Relative Strength Index (RSI) 67.08 49.36
Support Level $38.12 $53.81
Resistance Level $40.00 $58.32
Average True Range (ATR) 1.26 1.73
MACD 0.13 0.15
Stochastic Oscillator 68.68 47.65

Price Performance

Historical Comparison
HRMY
VVX

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

Share on Social Networks: